Shareholders Meetings

Share capital and voting rights*

  • Share capital: €5,034 582.90
  • Number of shares outstanding: 100,691,658
  • Total number of voting rights: 106,134,467

*As of May 31, 2026

26
Jun 2017
20:00 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Voting Results [FR]

Download the PDF file
13
Jun 2017
17:09 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Management Report

Download the PDF file
13
Jun 2017
16:36 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report from the board of directors

Download the PDF file
12
Jun 2017
11:33 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – AGM Brochure

Download the PDF file
12
Jun 2017
11:29 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Information regarding the director nominees

Download the PDF file
12
Jun 2017
11:22 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Voting form

Download the PDF file
12
Jun 2017
11:20 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the regulated agreements

Download the PDF file
12
Jun 2017
10:07 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the consolidated financial statements

Download the PDF file
12
Jun 2017
09:45 E.S.T.

Shareholders’ General Meeting – June 26, 2017 – Report on the financial statements

Download the PDF file
22
May 2017
20:50 E.S.T.

Notice of combined shareholders’ meeting of June 26, 2017

Download the PDF file

Get updates

Get the latest on gene-editing innovation, financial and business news from Cellectis with our email alert service.

Subscribe now